A Classified List of Diseases and an Alphabetical List of the Causes of Death
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
ICD-10-CM Expert for SNF, IRF, and LTCH the Complete Official Code Set Codes Valid from October 1, 2018 Through September 30, 2019
EXPERT 2019 ICD-10-CM Expert for SNF, IRF, and LTCH The complete official code set Codes valid from October 1, 2018 through September 30, 2019 Power up your coding optum360coding.com ITSN_ITSN19_CVR.indd 1 12/4/17 2:54 PM Contents Preface ................................................................................ iii ICD-10-CM Index to Diseases and Injuries .......................... 1 ICD-10-CM Official Preface ........................................................................iii Characteristics of ICD-10-CM ....................................................................iii ICD-10-CM Neoplasm Table ............................................ 331 What’s New for 2019 .......................................................... iv ICD-10-CM Table of Drugs and Chemicals ...................... 349 Official Updates ............................................................................................iv Proprietary Updates ...................................................................................vii ICD-10-CM Index to External Causes ............................... 397 Introduction ....................................................................... ix ICD-10-CM Tabular List of Diseases and Injuries ............ 433 History of ICD-10-CM .................................................................................ix Chapter 1. Certain Infectious and Parasitic Diseases (A00-B99) .........................................................................433 How to Use ICD-10-CM Expert for Skilled Nursing Chapter -
Café Au Lait Spots As a Marker of Neuropaediatric Diseases
Mini Review Open Access J Neurol Neurosurg Volume 3 Issue 5 - May 2017 DOI: 10.19080/OAJNN.2017.03.555622 Copyright © All rights are reserved by Francisco Carratalá-Marco Café Au Lait Spots as a Marker of Neuropaediatric Diseases Francisco Carratalá-Marco1*, Rosa María Ruiz-Miralles2, Patricia Andreo-Lillo1, Julia Dolores Miralles-Botella3, Lorena Pastor-Ferrándiz1 and Mercedes Juste-Ruiz2 1Neuropaediatric Unit, University Hospital of San Juan de Alicante, Spain 2Paediatric Department, University Hospital of San Juan de Alicante, Spain 3Dermatology Department, University Hospital of San Juan de Alicante, Spain Submission: March 22, 2017; Published: May 10, 2017 *Corresponding author: Francisco Carratalá-Marco, Neuropaediatric Unit, University Hospital of San Juan de Alicante, Spain, Tel: ; Email: Abstract Introduction: want to know in which The measure,Café au lait the spots presence (CALS) of isolated are shown CALS in representsthe normal a population risk factor forwithout neurological pathological disease. significance, although they could also be criteria for some neurologic syndromes. Unspecific association with general neurologic illnesses has been less frequently described. We Patients and methods: We set up an observational transversal study of cases, patients admitted for neuropaediatric reasons (NPP; n=49) excluding all the patients suffering from neurologic illnesses associated to CALS, and controls, a hospital simultaneously admitted pediatric population for non-neurologic causes (CP; n=101) since October 2012 to January 2013. The data were collected from the clinical reports at admission, and then analyzed by SPSS 22.0 statistical package, and the Stat Calc module of EpiInfo 7.0, following the ethics current rules of the institution for observational studies. -
ICD-10-CM TABULAR LIST of DISEASES and INJURIES 2018 Addenda No Change Chapter 1 No Change Certain Infectious and Parasitic Diseases (A00-B99)
ICD-10-CM TABULAR LIST of DISEASES and INJURIES 2018 Addenda No Change Chapter 1 No Change Certain infectious and parasitic diseases (A00-B99) No Change Intestinal infectious diseases (A00-A09) No Change A04 Other bacterial intestinal infections No Change A04.7 Enterocolitis due to Clostridium difficile Add A04.71 Enterocolitis due to Clostridium difficile, recurrent Add A04.72 Enterocolitis due to Clostridium difficile, not specified as recurrent No Change A05 Other bacterial foodborne intoxications, not elsewhere classified No Change Excludes1: Revise from Clostridium difficile foodborne intoxication and infection (A04.7) Revise to Clostridium difficile foodborne intoxication and infection (A04.7-) No Change Helminthiases (B65-B83) No Change B81 Other intestinal helminthiases, not elsewhere classified No Change Excludes1: Revise from angiostrongyliasis due to Parastrongylus cantonensis (B83.2) Revise to angiostrongyliasis due to: Add Angiostrongylus cantonensis (B83.2) Add Parastrongylus cantonensis (B83.2) No Change B81.3 Intestinal angiostrongyliasis Revise from Angiostrongyliasis due to Parastrongylus costaricensis Revise to Angiostrongyliasis due to: Add Angiostrongylus costaricensis Add Parastrongylus costaricensis No Change Chapter 2 No Change Neoplasms (C00-D49) No Change Malignant neoplasms of ill-defined, other secondary and unspecified sites (C76-C80) No Change C79 Secondary malignant neoplasm of other and unspecified sites Delete Excludes2: lymph node metastases (C77.0) No Change C79.1 Secondary malignant neoplasm of bladder -
EFFECTIVE NEBRASKA DEPARTMENT of 01/01/2017 HEALTH and HUMAN SERVICES 173 NAC 1 I TITLE 173 COMMUNICABLE DISEASES CHAPTER 1
EFFECTIVE NEBRASKA DEPARTMENT OF 01/01/2017 HEALTH AND HUMAN SERVICES 173 NAC 1 TITLE 173 COMMUNICABLE DISEASES CHAPTER 1 REPORTING AND CONTROL OF COMMUNICABLE DISEASES TABLE OF CONTENTS SECTION SUBJECT PAGE 1-001 SCOPE AND AUTHORITY 1 1-002 DEFINITIONS 1 1-003 WHO MUST REPORT 2 1-003.01 Healthcare Providers (Physicians and Hospitals) 2 1-003.01A Reporting by PA’s and APRN’s 2 1-003.01B Reporting by Laboratories in lieu of Physicians 3 1-003.01C Reporting by Healthcare Facilities in lieu of Physicians for 3 Healthcare Associated Infections (HAIs) 1-003.02 Laboratories 3 1-003.02A Electronic Ordering of Laboratory Tests 3 1-004 REPORTABLE DISEASES, POISONINGS, AND ORGANISMS: 3 LISTS AND FREQUENCY OF REPORTS 1-004.01 Immediate Reports 4 1-004.01A List of Diseases, Poisonings, and Organisms 4 1-004.01B Clusters, Outbreaks, or Unusual Events, Including Possible 5 Bioterroristic Attacks 1-004.02 Reports Within Seven Days – List of Reportable Diseases, 5 Poisonings, and Organisms 1-004.03 Reporting of Antimicrobial Susceptibility 8 1-004.04 New or Emerging Diseases and Other Syndromes and Exposures – 8 Reporting and Submissions 1-004.04A Criteria 8 1-004.04B Surveillance Mechanism 8 1-004.05 Sexually Transmitted Diseases 9 1-004.06 Healthcare Associated Infections 9 1-005 METHODS OF REPORTING 9 1-005.01 Health Care Providers 9 1-005.01A Immediate Reports of Diseases, Poisonings, and Organisms 9 1-005.01B Immediate Reports of Clusters, Outbreaks, or Unusual Events, 9 Including Possible Bioterroristic Attacks i EFFECTIVE NEBRASKA DEPARTMENT OF -
Federal Register/Vol. 69, No. 194/Thursday, October 7, 2004
Federal Register / Vol. 69, No. 194 / Thursday, October 7, 2004 / Rules and Regulations 60083 Regulations Branch, Office of drawback requested on the drawback war are decided fairly, consistently, and Regulations and Rulings, U.S. Customs entry. This is determined as follows: based on all available medical and Border Protection. However, * * * * * information concerning the diseases personnel from other offices I 4. In § 191.171, a new paragraph (c) is associated with detention or internment participated in its development. added to read as follows: as a prisoner of war. DATES: List of Subjects in 19 CFR Part 191 This interim final rule is § 191.171 General; drawback allowance. effective October 7, 2004. Comments Claims, Commerce, CBP duties and * * * * * must be received on or before November inspection, Drawback. (c) Merchandise processing fees. In 8, 2004. cases where the requirements of Amendments to the Regulations ADDRESSES: Written comments may be paragraph (b)(1) of this section have submitted by: mail or hand-delivery to I For the reasons stated above, part 191 been met, merchandise processing fees Director, Regulations Management of the CBP Regulations (19 CFR part 191) will be eligible for drawback. (00REG1), Department of Veterans is amended as follows: Approved: October 4, 2004. Affairs, 810 Vermont Ave., NW., Room Robert C. Bonner, 1068, Washington, DC 20420; fax to PART 191 — DRAWBACK Commissioner, U.S. Customs and Border (202) 273–9026; e-mail to I 1. The general authority citation for Protection. [email protected]; or, through part 191 continues to read as follows: Timothy E. Skud, http://www.Regulations.gov. Comments Deputy Assistant Secretary of the Treasury. -
Hereditary Gingival Fibromatosiswith Hemophilia B
Vol. 17, No ?. UDC 616.311.2:616.151.5 CODEN: ASCRBK 1983 YU ISSN: 0001—7019 Original paper Hereditary gingival fibromatosis with hemophilia B Ilija Škrinjarić, Miljenko Bačić and Zvonko Poje Department of Children’s and Preventive Dentistry, Department of Periodontology and Department of Orthodontics, Faculty of Dentistry, University of Zagreb Received, February 7, 1983 Summary This work presents a case report of a generalized form of hereditary gin gival fibromatosis with hemophilia B as an accompanying disease. In the family of proband, consisting of 28 members, fibromatosis was present in 9 (4 males and 5 females). The pedigree analysis confirmed that gingival fibro matosis was transmited through three generations as an autosomal dominant trait. Neither proband, nor any other family member, showed other abnorma lities. Blood coagulation tests reveald hemophilia B (Christmas disease) in the proband. The coagulogram showed prolonged kaolin cephalin time (50 se conds) and low concentration of factor IX (F IX 18%). The case report sug gests that hemophilia B should be included in the list of diseases associated with gingival fibromatosis. Key words: gingival fibromatosis, hemophilia B Hereditary gingival fibromatosis manifests as an isolated trait, accompanied by other abnormalities or disease, or as a symptom of a specific syndrome. The most common clinical abnormalities associated with gingival fibromatosis are hypertrichosis, epilepsy, mental retardation, and defects of the eye, ear, nose, skeleton and nails (Fletcher1, Gorlin et a I.2, Jorgenson and Cocker3). Isolated gingival fibromatosis without other abnormalities is considered a special entity which differs from the fibromatosis accompanied by hypertrichosis, epilepsy or mental retardation (Cohen4). -
Viability of B. Typhosus in Stored Shell Oysters
PUBLIC HEALTH REPORTS VOL. 40 APRIL 24, 1925 No. 17 VIABILITY OF B. TYPHOSUS IN STORED SHELL OYSTERS By CONRAD KINYOuN, Assistant Bacteriologist, hlygienic Laboratory, United Stztes Ptiblic Ilealti Serviee The object of this work was to determine whether oysters con- taminated with B. typhosuis and then stored unider uisual market conditions woul(l remain potentially infectious over a length of time sufficient to allow them to reach the consumer. Conflicting opinions are now current as to the length of time the causative agent of typhoid fever can remain viable in the oyster, and even as to whether the oyster can harbor the organisms at all. Obviouisly an oyster which harbors typhoidl organismns for as short a time as 24 hours becomes a potential infecting, agent for thlat time. Practi- cally it is of interest to know whether the time elapsing between the remov-al of the oyster from the bed and( actual consumption after passing through customary commercial channels is sufficient for oysters to rid themselves of possible infection. As early as 1603, oysters were incriminate(d in intestinal disor(lers, when suspicion was directed toward them by an illness of Henry IV of France (7). It was not uIntil the close of the nineteenth century, however, that oysters and shellfislh as agents of (lisease transmission receive(d particular attention. In October, 1894, Conn focused attention on the oyster by his investigation of the now famous Wesleyan outbreak, an(d thoughl only thlree outbreaks of typhoid fever were definitely traced to the oyster before 19,25, these stimulated wide interest and consequent study, with atten(lant epidemiological and bacteriological investigations. -
Study Guide Medical Terminology by Thea Liza Batan About the Author
Study Guide Medical Terminology By Thea Liza Batan About the Author Thea Liza Batan earned a Master of Science in Nursing Administration in 2007 from Xavier University in Cincinnati, Ohio. She has worked as a staff nurse, nurse instructor, and level department head. She currently works as a simulation coordinator and a free- lance writer specializing in nursing and healthcare. All terms mentioned in this text that are known to be trademarks or service marks have been appropriately capitalized. Use of a term in this text shouldn’t be regarded as affecting the validity of any trademark or service mark. Copyright © 2017 by Penn Foster, Inc. All rights reserved. No part of the material protected by this copyright may be reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without permission in writing from the copyright owner. Requests for permission to make copies of any part of the work should be mailed to Copyright Permissions, Penn Foster, 925 Oak Street, Scranton, Pennsylvania 18515. Printed in the United States of America CONTENTS INSTRUCTIONS 1 READING ASSIGNMENTS 3 LESSON 1: THE FUNDAMENTALS OF MEDICAL TERMINOLOGY 5 LESSON 2: DIAGNOSIS, INTERVENTION, AND HUMAN BODY TERMS 28 LESSON 3: MUSCULOSKELETAL, CIRCULATORY, AND RESPIRATORY SYSTEM TERMS 44 LESSON 4: DIGESTIVE, URINARY, AND REPRODUCTIVE SYSTEM TERMS 69 LESSON 5: INTEGUMENTARY, NERVOUS, AND ENDOCRINE S YSTEM TERMS 96 SELF-CHECK ANSWERS 134 © PENN FOSTER, INC. 2017 MEDICAL TERMINOLOGY PAGE III Contents INSTRUCTIONS INTRODUCTION Welcome to your course on medical terminology. You’re taking this course because you’re most likely interested in pursuing a health and science career, which entails proficiencyincommunicatingwithhealthcareprofessionalssuchasphysicians,nurses, or dentists. -
Characterization of a Meiotic Recombination Hotspot in Arabidopsis Thaliana Hossein Khademian
Characterization of a meiotic recombination hotspot in Arabidopsis thaliana Hossein Khademian To cite this version: Hossein Khademian. Characterization of a meiotic recombination hotspot in Arabidopsis thaliana. Agricultural sciences. Université Paris Sud - Paris XI, 2012. English. NNT : 2012PA112051. tel- 00800551 HAL Id: tel-00800551 https://tel.archives-ouvertes.fr/tel-00800551 Submitted on 14 Mar 2013 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. UNIVERSITE PARIS-SUD 11 U.F.R. Scientifique d’Orsay Thèse Présentée pour l’obtention du grade de Docteur en Sciences de l’Université Paris-Sud XI Spécialité : Sciences du Végétal par Hossein KHADEMIAN Caractérisation d’un point chaud de recombinaison méiotique chez Arabidopsis thaliana Composition du jury : Valérie BORDE Rapporteur Michel DRON Président du Jury Corinne GREY Examinateur Christine MEZARD Directeur de Thèse Minoo RASSOULZADEGAN Rapporteur Abstract Meiotic recombination initiated in prophase I of meiosis generates either crossovers (COs), which are reciprocal exchanges between chromosome segments, or gene conversion not associated to crossovers (NCOs). Both kinds of events occur in narrow regions (less than 10 kilobases) called hotspots, which are distributed non-homogenously along chromosomes. The aim of my PhD was the characterization of a hotspot of meiotic recombination (named 14a) in Arabidopsis thaliana (i) across different accessions (ii) in msh4 mutant, a gene involved in CO formation. -
Eye Disease 1 Eye Disease
Eye disease 1 Eye disease Eye disease Classification and external resources [1] MeSH D005128 This is a partial list of human eye diseases and disorders. The World Health Organisation publishes a classification of known diseases and injuries called the International Statistical Classification of Diseases and Related Health Problems or ICD-10. This list uses that classification. H00-H59 Diseases of the eye and adnexa H00-H06 Disorders of eyelid, lacrimal system and orbit • (H00.0) Hordeolum ("stye" or "sty") — a bacterial infection of sebaceous glands of eyelashes • (H00.1) Chalazion — a cyst in the eyelid (usually upper eyelid) • (H01.0) Blepharitis — inflammation of eyelids and eyelashes; characterized by white flaky skin near the eyelashes • (H02.0) Entropion and trichiasis • (H02.1) Ectropion • (H02.2) Lagophthalmos • (H02.3) Blepharochalasis • (H02.4) Ptosis • (H02.6) Xanthelasma of eyelid • (H03.0*) Parasitic infestation of eyelid in diseases classified elsewhere • Dermatitis of eyelid due to Demodex species ( B88.0+ ) • Parasitic infestation of eyelid in: • leishmaniasis ( B55.-+ ) • loiasis ( B74.3+ ) • onchocerciasis ( B73+ ) • phthiriasis ( B85.3+ ) • (H03.1*) Involvement of eyelid in other infectious diseases classified elsewhere • Involvement of eyelid in: • herpesviral (herpes simplex) infection ( B00.5+ ) • leprosy ( A30.-+ ) • molluscum contagiosum ( B08.1+ ) • tuberculosis ( A18.4+ ) • yaws ( A66.-+ ) • zoster ( B02.3+ ) • (H03.8*) Involvement of eyelid in other diseases classified elsewhere • Involvement of eyelid in impetigo -
DIAGNOSIS and TREATMENT of BRUCELLOSIS (Undulant Fever)
DIAGNOSIS AND TREATMENT OF BRUCELLOSIS (Undulant Fever) CHARLES L. HARTSOCK, M.D. Not only the treatment but also the diagnosis of undulant fever are far from being satisfactory, although many types of therapy are being tried and critically evaluated. Because of the tremendous scope of the disease, frequent discussions and reappraisals of our ideas about bru- cellosis will be absolutely essential for some time. Some physicians more or less disregard brucellosis and even scoff at the chronic phase of this new intruder in the realm of human disease. Others are overenthusi- astic and attempt to explain many vague and indefinite problems upon the basis of chronic brucellosis without sufficient evidence. Still other physicians have lost their original enthusiasm and have reverted to the first viewpoint, probably because of the great difficulty in coping with the caprices and vagaries of this disease and the marked uncertainties in diagnosis and treatment. Even though this disease is extremely protean and remarkably bizarre in its manifestations, it is a disease of known causative organism to which the generic term of brucella has been given. The original infection in man was traced to the drinking of goat's milk on the Island of Malta, and for many years this disease was known as Malta fever. Because of the undulating character of the fever with a tendency for remissions and recurrences, it was later called undulant fever which proved to be a very poor description of the febrile reaction in many instances. Brucellosis is the more specific term derived from the organism causing the disease. Three strains of the brucella organism have been isolated and named for their respective hosts: b. -
20) Thyrotoxicosis
1 Міністерство охорони здоров’я України Харківський національний медичний університет Кафедра Внутрішньої медицини №3 Факультет VI по підготовці іноземних студентів ЗАТВЕРДЖЕНО на засіданні кафедри внутрішньої медицини №3 «29» серпня 2016 р. протокол № 13 Зав. кафедри _______д.мед.н., професор Л.В. Журавльова МЕТОДИЧНІ ВКАЗІВКИ для студентів з дисципліни «Внутрішня медицина (в тому числі з ендокринологією) студенти 4 курсу І, ІІ, ІІІ медичних факультетів, V та VI факультетів по підготовці іноземних студентів Тиреотоксикоз. Клінічні форми, діагностика, лікування. Пухлини щитоподібної залоз та патологія при щитоподібних залоз Харків 2016 2 Topic – «Thyrotoxicosis. Clinical forms, diagnostic, treatment. Tumors of thyreoid gland and pathology of parathyroid glands» 1.The number of hours - 5 Actuality: Thyroid gland disease is one of the most popular in Ukraine affect patients of working age, degrade the quality of life and reduce its duration. Aim: 1. To learn the method of determining the etiologic factors and pathogenesis of diffuse toxic goiter. Work out techniques of palpation of the thyroid gland. 2. To familiarize students with the classifications of goiter by OV.Nikolaєv (1955 г.) And WHO (1992 г.). 3. To distinguish a typical clinical picture of diffuse toxic goiter (DTG). 4. To acquainte with the atypical clinical variants of diffuse toxic goiter. 5. To acquaint students with the possible complications of DTG. 6. To determine the basic diagnostic criteria for Graves' disease 7. To make a plan to examinate patients with Graves' disease. 8. Analysis of the results of laboratory and instrumental studies, which are used for the diagnosis of DTG. 9. Differential diagnosis between DTG and goiter 10. Technology of formulation of the diagnosis of DTG and goiter.